Published on GHDx (https://ghdx.healthdata.org)

HPV Vaccination Cost Effectiveness Estimates

General Info

Provider 
Institute for Health Metrics and Evaluation (IHME)
Geography 
Afghanistan (AFG)
Albania (ALB)
Algeria (DZA)
Andorra (AND)
Angola (AGO)
Namibe
Antigua and Barbuda (ATG)
Argentina (ARG)
Armenia (ARM)
Australia (AUS)
Austria (AUT)
Azerbaijan (AZE)
Bahamas (BHS)
Bahrain (BHR)
Bangladesh (BGD)
Barbados (BRB)
Belarus (BLR)
Belgium (BEL)
Belize (BLZ)
Benin (BEN)
Bhutan (BTN)
Bolivia (BOL)
Bosnia and Herzegovina (BIH)
Botswana (BWA)
Brazil (BRA)
Brunei Darussalam (BRN)
Bulgaria (BGR)
Burkina Faso (BFA)
Burundi (BDI)
Cabo Verde (CPV)
Cambodia (KHM)
Cameroon (CMR)
Canada (CAN)
Central African Republic (CAF)
Chad (TCD)
Chile (CHL)
China (CHN)
Colombia (COL)
Comoros (COM)
Congo (COG)
Costa Rica (CRI)
Croatia (HRV)
Cuba (CUB)
Cyprus (CYP)
Czechia (CZE)
Côte d'Ivoire (CIV)
Democratic People's Republic of Korea (PRK)
Democratic Republic of the Congo (COD)
Denmark (DNK)
Djibouti (DJI)
Dominica (DMA)
Dominican Republic (DOM)
Ecuador (ECU)
Egypt (EGY)
El Salvador (SLV)
Equatorial Guinea (GNQ)
Eritrea (ERI)
Estonia (EST)
Eswatini (SWZ)
Ethiopia (ETH)
Fiji (FJI)
Finland (FIN)
France (FRA)
Gabon (GAB)
Gambia (GMB)
Georgia (GEO)
Germany (DEU)
Ghana (GHA)
Global
Greece (GRC)
Greenland (GRL)
Grenada (GRD)
Guatemala (GTM)
Guinea (GIN)
Guinea-Bissau (GNB)
Guyana (GUY)
Haiti (HTI)
Honduras (HND)
Hungary (HUN)
Iceland (ISL)
India (IND)
Indonesia (IDN)
Iran (Islamic Republic of) (IRN)
Iraq (IRQ)
Ireland (IRL)
Israel (ISR)
Italy (ITA)
Jamaica (JAM)
Japan (JPN)
Jordan (JOR)
Kazakhstan (KAZ)
Kenya (KEN)
Kiribati (KIR)
Kuwait (KWT)
Kyrgyzstan (KGZ)
Lao People's Democratic Republic (LAO)
Latvia (LVA)
Lebanon (LBN)
Lesotho (LSO)
Liberia (LBR)
Libya (LBY)
Lithuania (LTU)
Luxembourg (LUX)
Madagascar (MDG)
Malawi (MWI)
Malaysia (MYS)
Maldives (MDV)
Mali (MLI)
Malta (MLT)
Marshall Islands (MHL)
Mauritania (MRT)
Mauritius (MUS)
Mexico (MEX)
Micronesia (Federated States of) (FSM)
Mongolia (MNG)
Montenegro (MNE)
Morocco (MAR)
Mozambique (MOZ)
Myanmar (MMR)
Nepal (NPL)
Netherlands (NLD)
New Zealand (NZL)
Nicaragua (NIC)
Niger (NER)
Nigeria (NGA)
North Macedonia (MKD)
Norway (NOR)
Oman (OMN)
Pakistan (PAK)
Palestine (PSE)
Panama (PAN)
Papua New Guinea (PNG)
Paraguay (PRY)
Alto Paraguay
Peru (PER)
Philippines (PHL)
Poland (POL)
Portugal (PRT)
Qatar (QAT)
Republic of Korea (KOR)
Republic of Moldova (MDA)
Romania (ROU)
Russian Federation (RUS)
Rwanda (RWA)
Saint Lucia (LCA)
Saint Vincent and the Grenadines (VCT)
Samoa (WSM)
Sao Tome and Principe (STP)
Saudi Arabia (SAU)
Senegal (SEN)
Serbia (SRB)
Seychelles (SYC)
Sierra Leone (SLE)
Singapore (SGP)
Slovakia (SVK)
Slovenia (SVN)
Solomon Islands (SLB)
Somalia (SOM)
South Africa (ZAF)
South Sudan (SSD)
Spain (ESP)
Sri Lanka (LKA)
Sudan (SDN)
Suriname (SUR)
Sweden (SWE)
Switzerland (CHE)
Syrian Arab Republic (SYR)
Taiwan (Province of China) (TWN)
Tajikistan (TJK)
Thailand (THA)
Timor-Leste (TLS)
Togo (TGO)
Tonga (TON)
Trinidad and Tobago (TTO)
Tunisia (TUN)
Turkmenistan (TKM)
Türkiye (TUR)
Uganda (UGA)
Ukraine (UKR)
United Arab Emirates (ARE)
United Kingdom (GBR)
Bermuda
United Republic of Tanzania (TZA)
United States of America (USA)
American Samoa, Guam, Northern Mariana Islands, Puerto Rico, United States Virgin Islands
Uruguay (URY)
Uzbekistan (UZB)
Vanuatu (VUT)
Venezuela (Bolivarian Republic of) (VEN)
Viet Nam (VNM)
Yemen (YEM)
Zambia (ZMB)
Zimbabwe (ZWE)
View all
Coverage type 
Global
Time period covered 
December, 2021 - December, 2021
Data type
Estimate
Summary 

The dataset contains predictions of the incremental cost-effectiveness ratios (ICERs) for the HPV vaccine in 195 countries. Predictions are based on meta-regression estimates of ICERs on three sets of independent variables (true variation measured by country characteristics, intervention characteristics, and bias variables). Data used in the meta-regression analysis are 613 ICERs from 75 studies in the Tufts University’s cost-effectiveness analysis registries, and additional extractions of ICERs for sensitivity analyses.

Keywords 
HPV, HPV vaccines, Health care costs

Citation

Contributors 
Institute for Health Metrics and Evaluation (IHME)
Funders 
Bill and Melinda Gates Foundation (BMGF)
Publisher 
Institute for Health Metrics and Evaluation (IHME)
Publication year 
2021
Suggested citation 
Institute for Health Metrics and Evaluation (IHME). HPV Vaccination Cost Effectiveness Estimates. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME), 2021.

Files (3)

Public files 
FileSize
Binary Data Data Release Information Sheet236.25 KB
Binary Data HPV Vaccine Cost Effectiveness Estimates [CSV]26.8 KB
Binary Data Codebook [CSV]13.63 KB
Source URL:https://ghdx.healthdata.org/record/ihme-data/hpv-cost-effectiveness